Risk factors of treatment failure of midurethral sling procedures for women with urinary stress incontinence

被引:94
作者
Stav, Kobi [1 ,2 ]
Dwyer, Peter L. [2 ]
Rosamilia, Anna [2 ,3 ]
Schierlitz, Lore [2 ]
Lim, Yik N. [2 ,3 ]
Lee, Joseph [2 ]
机构
[1] Mercy Hosp Women, Urogynaecol Dept, Heidelberg, Vic 3084, Australia
[2] Univ Melbourne, Dept Urogynaecol, Mercy Hosp Women, Melbourne, Vic, Australia
[3] Monash Univ, Monash Med Ctr, Dept Urogynaecol, Melbourne, Vic 3004, Australia
关键词
Midurethral sling; Multivariate analysis; Outcome; Risk factors; Stress urinary incontinence; FREE VAGINAL TAPE; STANDARDIZATION SUB-COMMITTEE; CONTINENCE-SOCIETY; PRESSURE; TVT; QUESTIONNAIRE;
D O I
10.1007/s00192-009-1020-9
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Midurethral sling (MUS) is now the first line surgical treatment for female stress urinary incontinence. Our aim was to identify predictors for MUS failure. A total of 1,225 consecutive women with urodynamic urinary stress incontinence had a synthetic MUS (955 retropubic and 270 transobturator) at our institution between 1999 and 2007. Multivariate analysis was performed in order to identify independent risk factors for failure. At a mean follow-up of 50 +/- 24 months (range, 12-114), the subjective cure rate was 84.7%. Multivariate analysis revealed that BMI > 25 (OR, 2.9), mixed incontinence (OR, 2.4), previous continence surgery (OR, 2.2), intrinsic sphincter deficiency (OR, 1.9), and diabetes mellitus (OR, 1.8) are significant independent predictors for MUS failure. Concomitant prolapse surgery decreased the likelihood of surgical failure after MUS (OR, 0.6). Patient's age and the type of the sling were not found to be risk factors for surgical failure.
引用
收藏
页码:149 / 155
页数:7
相关论文
共 29 条
  • [1] Abrams P, 2002, NEUROUROL URODYNAM, V21, P167, DOI 10.1002/nau.10052
  • [2] The effect of concomitant prolapse repair on sling outcomes
    Anger, Jennifer T.
    Litwin, Mark S.
    Wang, Qin
    Pashos, Chris L.
    Rodriguez, Larissa V.
    [J]. JOURNAL OF UROLOGY, 2008, 180 (03) : 1003 - 1006
  • [3] Risk factors associated with failure 1 year after retropubic or transobturator midurethral slings
    Barber, Matthew D.
    Kleeman, Steven
    Karram, Mickey M.
    Paraiso, Marie Fidela R.
    Ellerkmann, Mark
    Vasavada, Sandip
    Walters, Mark D.
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2008, 199 (06) : 666.e1 - 666.e7
  • [4] Short forms of two condition-specific quality-of-life questionnaires for women with pelvic floor disorders (PFDI-20 and PFIQ-7)
    Barber, MD
    Walters, MD
    Bump, RC
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2005, 193 (01) : 103 - 113
  • [5] Are slings now the gold standard treatment for the management of female urinary stress incontinence and if so which technique?
    Bemelmans, BLH
    Chapple, CR
    [J]. CURRENT OPINION IN UROLOGY, 2003, 13 (04) : 301 - 307
  • [6] Are there any factors predicting the cure and complication rates of tension-free vaginal tape?
    Çetinel, B
    Demirkesen, O
    Onal, B
    Akkus, E
    Alan, C
    Can, G
    [J]. INTERNATIONAL UROGYNECOLOGY JOURNAL, 2004, 15 (03) : 188 - 193
  • [7] Transvaginal vs transobturator approach for synthetic sling placement in patients with stress urinary incontinence
    Charalambous, S.
    Touloupidis, S.
    Fatles, G.
    Papatsoris, A. G.
    Kalaitzis, Ch.
    Giannakopoulos, S.
    Rombis, V.
    [J]. INTERNATIONAL UROGYNECOLOGY JOURNAL, 2008, 19 (03) : 357 - 360
  • [8] Analysis of risk factors associated with surgical failure of inside-out transobturator vaginal tape for treating urodynamic stress incontinence
    Chen, Huey-Yi
    Yeh, Lian-Shung
    Chang, Wei-Chun
    Ho, Ming
    [J]. INTERNATIONAL UROGYNECOLOGY JOURNAL, 2007, 18 (04) : 443 - 447
  • [9] Patient related risk factors for recurrent stress urinary incontinence surgery in women treated at a tertiary care center
    Daneshgari, Firouz
    Moore, Courtenay
    Frinjari, Hassan
    Babineau, Denise
    [J]. JOURNAL OF UROLOGY, 2006, 176 (04) : 1493 - 1499
  • [10] Delorme E, 2001, PROG UROL, V11, P1306